Uploaded July 2025 | Updated November 2026, 8 hours ago
Global cancer cases are increasing, and addressing this challenge requires bold innovation. At Bayer, we are driven by a relentless commitment to making a difference. Through collaborations with partners such as the Broad Institute of MIT and Harvard, Orion, and Vividion, we are exploring investigational therapies and pursuing potential breakthroughs to provide patients with new opportunities and options to live healthier, longer lives.
Global cancer cases are increasing, and addressing this challenge requires bold innovation. At Bayer, we are driven by a relentless commitment to making a difference. Through collaborations with partners such as the Broad Institute of MIT and Harvard, Orion, and Vividion, we are exploring investigational therapies and pursuing potential breakthroughs to provide patients with new opportunities and options to live healthier, longer lives.










